Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Events

Vancomycin-resistant enterococcal colonization appears associated with increased mortality among allogeneic hematopoietic stem cell transplant recipients

Abstract

There are no cohort studies describing outcomes of patients colonized with vancomycin-resistant enterococci (VRE) undergoing allogeneic hematopoietic stem cell transplantation (AHSCT). We therefore conducted a retrospective cohort study of 217 consecutive adults undergoing AHSCT at the Mayo Clinic (Rochester, MN, USA) from 1998 to 2004. We analyzed the association between VRE colonization prior to transplant and 100-day post transplant mortality and morbidity. We identified 22 pretransplant VRE colonized patients and 195 non-colonized patients. Both groups had similar baseline characteristics with the following six exceptions. Colonized patients were more likely to have had pretransplant Clostridium difficile-associated diarrhea, pretransplant acute renal failure, AML, Cy/TBI conditioning, decreased platelet count at time of transplantation and myeloablative conditioning regimens. Overall, patients colonized with VRE were twice as likely to die by day 100 post transplant compared to non-colonized patients (hazard ratio: 2.1, P=0.028). This association persisted even after adjusting for differences in baseline characteristics. Increased mortality in the colonized group correlated with the presence of VRE bacteremia. Overall, pretransplant VRE colonization appears to be an independent risk factor for increased mortality post-AHSCT.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Biedenbach DJ, Moet GJ, Jones RN . Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997–2002). Diagn Microbiol Infect Dis 2004; 50: 59–69.

    Article  CAS  PubMed  Google Scholar 

  2. Edmond MB, Ober JF, Dawson JD, Weinbaum DL, Wenzel RP . Vancomycin-resistant enterococcal bacteremia: natural history and attributable mortality. Clin Infect Dis 1996; 23: 1234–1239.

    Article  CAS  PubMed  Google Scholar 

  3. Poduval RD, Kamath RP, Corpuz M, Norkus EP, Pitchumoni CS . Clostridium difficile and vancomycin-resistant enterococcus: the new nosocomial alliance. Am J Gastroenterol 2000; 95: 3513–3515.

    Article  CAS  PubMed  Google Scholar 

  4. Joels CS, Matthews BD, Sigmon LB, Hasan R, Lohr CE, Kercher KW et al. Clinical characteristics and outcomes of surgical patients with vancomycin-resistant enterococcal infections. Am Surg 2003; 69: 514–519.

    PubMed  Google Scholar 

  5. El-Khoury J, Fishman JA . Linezolid in the treatment of vancomycin-resistant Enterococcus faecium in solid organ transplant recipients: report of a multicenter compassionate-use trial. Transpl Infect Dis 2003; 5: 121–125.

    Article  CAS  PubMed  Google Scholar 

  6. Yoo JH, Lee DG, Choi SM, Choi JH, Shin WS, Kim M et al. Vancomycin-resistant enterococcal bacteremia in a hematology unit: molecular epidemiology and analysis of clinical course. J Korean Med Sci 2005; 20: 169–176.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. DiazGranados CA, Jernigan JA . Impact of vancomycin resistance on mortality among patients with neutropenia and enterococcal bloodstream infection. J Infect Dis 2005; 191: 588–595.

    Article  CAS  PubMed  Google Scholar 

  8. Brennen C, Wagener MM, Muder RR . Vancomycin-resistant Enterococcus faecium in a long-term care facility. J Am Geriatr Soc 1998; 46: 157–160.

    Article  CAS  PubMed  Google Scholar 

  9. Patel R . Clinical impact of vancomycin-resistant enterococci. J Antimicrob Chemother 2003; 51 (Suppl 3): iii13–iii21.

    CAS  PubMed  Google Scholar 

  10. Zaas AK, Song X, Tucker P, Perl TM . Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci. Clin Infect Dis 2002; 35: 1139–1146.

    Article  PubMed  Google Scholar 

  11. Johnston PB, Elliott MA, Ansell SM, Dispenzieri A, Gastineau DA, Gertz MA et al. Colonization with vancomycin-resistant enterococcus correlates with poor outcome in patients undergoing allogeneic blood and marrow transplants. Blood 2000; 96: 786a.

    Google Scholar 

  12. Kumar S, DeLeve LD, Kamath PS, Tefferi A . Hepatic veno-occlusive disease (sinusoidal obstruction syndrome) after hematopoietic stem cell transplantation. Mayo Clin Proc 2003; 78: 589–598.

    Article  Google Scholar 

  13. Cutler C, Antin JH . An overview of hematopoietic stem cell transplantation. Clin Chest Med 2005; 26: 517–527.

    Article  PubMed  Google Scholar 

  14. Sloan LM, Uhl JR, Vetter EA, Schleck CD, Harmsen WS, Manahan J et al. Comparison of the Roche LightCycler vanA/vanB detection assay and culture for detection of vancomycin-resistant enterococci from perianal swabs. J Clin Microbiol 2004; 42: 2636–2643.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Mielcarek M, Storb R . Graft-vs-host disease after non-myeloablative hematopoietic cell transplantation. Leuk Lymphoma 2005; 46: 1251–1260.

    Article  CAS  Google Scholar 

  16. Sorror ML, Maris MB, Storer B, Sandmaier BM, Diaconescu R, Flowers C et al. Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities. Blood 2004; 104: 961–968.

    Article  CAS  Google Scholar 

  17. Weinstock DM, Conlon M, Iovino C, Aubrey T, Gudiol C, Riedel E et al. Colonization, bloodstream infection, and mortality caused by vancomycin-resistant enterococcus early after allogeneic hematopoietic stem cell transplant. Biol Blood Marrow Transplant 2007; 13: 615–621.

    Article  PubMed  Google Scholar 

  18. Gratwohl A, Brand R, Apperley J, Biezen Av A, Bandini G, Devergie A et al. Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia. Blood 2002; 100: 3877–3886.

    Article  CAS  Google Scholar 

  19. Gratwohl A, Hermans J, Apperley J, Arcese W, Bacigalupo A, Bandini G et al. Acute graft-versus-host disease: grade and outcome in patients with chronic myelogenous leukemia. Working Party Chronic Leukemia of the European Group for Blood and Marrow Transplantation. Blood 1995; 86: 813–818.

    CAS  PubMed  Google Scholar 

  20. Dubberke ER, Hollands JM, Georgantopoulos P, Augustin K, DiPersio JF, Mundy LM et al. Vancomycin-resistant enterococcal bloodstream infections on a hematopoietic stem cell transplant unit: are the sick getting sicker? Bone Marrow Transplant 2006; 38: 813–819.

    Article  CAS  Google Scholar 

  21. Avery R, Kalaycio M, Pohlman B, Sobecks R, Kuczkowski E, Andresen S et al. Early vancomycin-resistant enterococcus (VRE) bacteremia after allogeneic bone marrow transplantation is associated with a rapidly deteriorating clinical course. Bone Marrow Transplant 2005; 35: 497–499.

    Article  CAS  Google Scholar 

  22. Such J, Runyon BA . Spontaneous bacterial peritonitis. Clin Infect Dis 1998; 27: 669–674; quiz 675–676.

    Article  CAS  PubMed  Google Scholar 

  23. Guarner C, Runyon BA, Young S, Heck M, Sheikh MY . Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites. J Hepatol 1997; 26: 1372–1378.

    Article  CAS  PubMed  Google Scholar 

  24. Runyon BA, Squier S, Borzio M . Translocation of gut bacteria in rats with cirrhosis to mesenteric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitis. J Hepatol 1994; 21: 792–796.

    Article  CAS  PubMed  Google Scholar 

  25. Tu W, Chen J, Xiao G . [Effects of quinacrine on gut-origin bacteria/endotoxin translocation in rats with gut ischemia/reperfusion injury]. Zhonghua Shao Shang Za Zhi 2001; 17: 301–303.

    CAS  PubMed  Google Scholar 

  26. Von Bultzingslowen I, Adlerberth I, Wold AE, Dahlen G, Jontell M . Oral and intestinal microflora in 5-fluorouracil treated rats, translocation to cervical and mesenteric lymph nodes and effects of probiotic bacteria. Oral Microbiol Immunol 2003; 18: 278–284.

    Article  CAS  PubMed  Google Scholar 

  27. Yao YM, Yu Y, Sheng ZY, Tian HM, Wang YP, Lu LR . Role of gut-derived endotoxaemia and bacterial translocation in rats after thermal injury: effects of selective decontamination of the digestive tract. Burns 1995; 21: 580–585.

    Article  CAS  PubMed  Google Scholar 

  28. Tsuji E, Hiki N, Nomura S, Fukushima R, Kojima J, Ogawa T et al. Simultaneous onset of acute inflammatory response, sepsis-like symptoms and intestinal mucosal injury after cancer chemotherapy. Int J Cancer 2003; 107: 303–308.

    Article  CAS  Google Scholar 

  29. Bonten MJ, Willems R, Weinstein RA . Vancomycin-resistant enterococci: why are they here, and where do they come from? Lancet Infect Dis 2001; 1: 314–325.

    Article  CAS  PubMed  Google Scholar 

  30. Wong MT, Kauffman CA, Standiford HC, Linden P, Fort G, Fuchs HJ et al. Effective suppression of vancomycin-resistant Enterococcus species in asymptomatic gastrointestinal carriers by a novel glycolipodepsipeptide, ramoplanin. Clin Infect Dis 2001; 33: 1476–1482.

    Article  CAS  PubMed  Google Scholar 

  31. Herrero IA, Issa NC, Patel R . Nosocomial spread of linezolid-resistant, vancomycin-resistant Enterococcus faecium. N Engl J Med 2002; 346: 867–869.

    Article  PubMed  Google Scholar 

  32. Long JK, Choueiri TK, Hall GS, Avery RK, Sekeres MA . Daptomycin-resistant Enterococcus faecium in a patient with acute myeloid leukemia. Mayo Clin Proc 2005; 80: 1215–1216.

    Article  PubMed  Google Scholar 

  33. Plosker GL, Figgitt DP . Linezolid: a pharmacoeconomic review of its use in serious Gram-positive infections. Pharmacoeconomics 2005; 23: 945–964.

    Article  PubMed  Google Scholar 

  34. Tsiatis AC, Manes B, Calder C, Billheimer D, Wilkerson KS, Frangoul H . Incidence and clinical complications of vancomycin-resistant enterococcus in pediatric stem cell transplant patients. Bone Marrow Transplant 2004; 33: 937–941.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R Patel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zirakzadeh, A., Gastineau, D., Mandrekar, J. et al. Vancomycin-resistant enterococcal colonization appears associated with increased mortality among allogeneic hematopoietic stem cell transplant recipients. Bone Marrow Transplant 41, 385–392 (2008). https://doi.org/10.1038/sj.bmt.1705912

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705912

Keywords

This article is cited by

Search

Quick links